结直肠癌
免疫印迹
植物化学
PI3K/AKT/mTOR通路
信号转导
体外
药理学
癌症研究
传统医学
癌症
生物
医学
计算生物学
基因
内科学
细胞生物学
生物化学
作者
Huihai Yang,Man Kit Cheung,Grace Gar-Lee Yue,Ping-Chung Leung,Chun-Kwok Wong,Clara Bik-San Lau
出处
期刊:Molecules
[Multidisciplinary Digital Publishing Institute]
日期:2021-10-05
卷期号:26 (19): 6032-6032
被引量:4
标识
DOI:10.3390/molecules26196032
摘要
Herba Patriniae (HP) are medicinal plants commonly used in colorectal cancer (CRC) patients. In this study, network pharmacology was used to predict the active components and key signaling pathways of HP in CRC. Patrinia heterophylla, one type of HP, was chosen for validation of the network pharmacology analysis. The phytochemical profile of Patrinia heterophylla water extract (PHW) was determined by UHPLC-MS. MTT, RT-PCR, and Western blot assays were performed to evaluate the bioactivities of PHW in colon cancer cells. Results showed that 15 potentially active components of HP interacted with 28 putative targets of CRC in the compound-target network, of which asperglaucide had the highest degree. Furthermore, the ErbB signaling pathway was identified as the pathway mediated by HP with the most potential against CRC. Both RT-PCR and Western blot results showed that PHW significantly downregulated the mRNA and protein levels of EGFR, PI3K, and AKT in HCT116 cells. Asperglaucide, present in PHW, exhibited an anti-migratory effect in HCT116 cells, suggesting that it could be an active component of PHW in CRC treatment. In conclusion, this study has provided the first scientific evidence to support the use of PHW in CRC and paved the way for further research into the underlying mechanisms of PHW against CRC.
科研通智能强力驱动
Strongly Powered by AbleSci AI